The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a medication for diabetes that's also being used for weight-loss, he's down 65 ...

Proposed federal dietary recommendations may bring new focus to what it means to eat healthy in 2025, but longstanding ...

The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...

On Christmas Day, billionaire Elon Musk shocked his followers by sharing a revealing post about his weight-loss journey.

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Branneisha Cooper was terrified of attending her first holiday gathering after starting Mounjaro. The 28-year-old ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...